Clinical Trial Update: Trial Using Octreotide to Enhance Liver Recovery After Hepatectomy [Phase 2]

View source ↗

Summary

Phase 2 trial investigating octreotide to enhance liver recovery after major liver resection was terminated, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatectomy Recovery
• Liver Disease Due to Major Liver Resection

Drugs mentioned

• OCTREOTIDE (OCTREOTIDE ACETATE)

Snippet

Sponsor: Fox Chase Cancer Center | Conditions: Major Liver Resection | Phase 2 | Status: TERMINATED | Results posted: 2022-05-26